The reiteration of a Buy rating and maintenance of a $300 price target by Canaccord Genuity analyst Kyle Mikson indicates a positive outlook for Illumina's stock. This news is likely to have a positive short-term impact on the stock price as it shows continued confidence in the company's performance and potential growth.